Sfoglia per Autore
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database
2020-01-01 Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients
2021-01-01 Facchin, S.; Buda, A.; Cardin, R.; Agbariah, N.; Zingone, F.; De Bona, M.; Zaetta, D.; Bertani, L.; Ghisa, M.; Barberio, B.; Savarino, E. V.
The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
2021-01-01 Barberio, B.; Zingone, F.; Bertani, L.; Savarino, E.
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study
2021-01-01 Barberio, B.; Cingolani, L.; Canova, C.; Barbieri, G.; Sablich, R.; Urbano, M. T.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Ferronato, A.; Buda, A.; Melatti, P.; Massimi, D.; Savarino, E. V.; Zingone, F.
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak
2021-01-01 Bertani, Lorenzo; Barberio, Brigida; Tricò, Domenico; Zanzi, Federico; Maniero, Daria; Ceccarelli, Linda; Marsilio, Ilaria; Coppini, Francesca; Lorenzon, Greta; Mumolo, Maria Gloria; Zingone, Fabiana; Costa, Francesco; Savarino, Edoardo Vincenzo
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
2021-01-01 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy
2021-01-01 Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy)
2021-01-01 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M
Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques
2021-01-01 Bodini, Giorgia; Demarzo, Maria Giulia; Djahandideh, Afscin; Ziola, Sebastiano; Risso, Paolo; Bertani, Lorenzo; Baldissarro, Isabella; Testa, Tommaso; Marchi, Santino; Savarino, Edoardo; Giannini, Edoardo Giovanni
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study
2021-01-01 Massimi, Davide; Barberio, Brigida; Bertani, Lorenzo; Costa, Francesco; Ferronato, Antonio; Facchin, Sonia; Cardin, Romilda; Cingolani, Linda; Casadei, Cesare; D’Incà, Renata; Zingone, Fabiana; Savarino, Edoardo Vincenzo
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers
2021-01-01 Capecchi, R.; Migliorini, P.; Zanzi, F.; Maltinti, S.; Puxeddu, I.; de Bortoli, N.; Bellini, M.; Costa, F.; Marchi, S.; Bertani, L.
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
2021-01-01 Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V.
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis
2021-01-01 Bertani, L.; Trico, D.; Zanzi, F.; Svizzero, G. B.; Coppini, F.; de Bortoli, N.; Bellini, M.; Antonioli, L.; Blandizzi, C.; Marchi, S.
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
2021-01-01 Visaggi, P.; Savarino, E.; Sciume, G.; Chio, T. D.; Bronzini, F.; Tolone, S.; Frazzoni, M.; Pugno, C.; Ghisa, M.; Bertani, L.; Bellini, M.; Savarino, V.; Peroni, D.; Marchi, S.; de Bortoli, N.
Inflammatory bowel diseases: Is there a role for nutritional suggestions?
2021-01-01 Bertani, L.; Ribaldone, D. G.; Bellini, M.; Mumolo, M. G.; Costa, F.
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients
2021-01-01 Bertani, L.; Trico, D.; Pugliese, D.; Privitera, G.; Linsalata, G.; Zanzi, F.; Gloria Mumolo, M.; Barberio, B.; Monzani, F.; Marchi, S.; Guidi, L.; Blandizzi, C.; Armuzzi, A.; Costa, F.
HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY
2021-01-01 Bertani, L; Barberio, B; Trico, D; Zanzi, F; Maniero, D; Ceccarelli, L; Marsilio, I; Minciotti, M; Coppini, F; Lorenzon, G; Mumolo, Mg; Zingone, F; Costa, F; Savarino, Ev
Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study
2021-01-01 Cusato, J.; Bertani, L.; Antonucci, M.; Tomasello, C.; Caviglia, G. P.; Dibitetto, S.; Massano, A.; Mangia, M.; Mula, J.; Ceccarelli, L.; Costa, F.; Zanzi, F.; Astegiano, M.; Ribaldone, D. G.; D'Avolio, A.
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis
2022-01-01 D'Antongiovanni, Vanessa; Pellegrini, Carolina; Benvenuti, Laura; Fornai, Matteo; Di Salvo, Clelia; Natale, Gianfranco; Ryskalin, Larisa; Bertani, Lorenzo; Lucarini, Elena; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Nemeth, Zoltan H; Haskó, György; Antonioli, Luca
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry
2022-01-01 Tapete, Gherardo; Bertani, Lorenzo; Pieraccini, Alberto; Lynch, Erica Nicola; Giannotta, Martina; Morganti, Riccardo; Biviano, Ivano; Naldini, Sara; Mumolo, Maria Gloria; De Nigris, Francesca; Calella, Francesca; Bagnoli, Siro; Minciotti, Moira; Maltinti, Simona; Rentini, Silvia; Ceccarelli, Linda; Lionetti, Paolo; Milla, Monica; Costa, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database | 1-gen-2020 | Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M | |
| Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients | 1-gen-2021 | Facchin, S.; Buda, A.; Cardin, R.; Agbariah, N.; Zingone, F.; De Bona, M.; Zaetta, D.; Bertani, L.; Ghisa, M.; Barberio, B.; Savarino, E. V. | |
| The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? | 1-gen-2021 | Barberio, B.; Zingone, F.; Bertani, L.; Savarino, E. | |
| A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study | 1-gen-2021 | Barberio, B.; Cingolani, L.; Canova, C.; Barbieri, G.; Sablich, R.; Urbano, M. T.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Ferronato, A.; Buda, A.; Melatti, P.; Massimi, D.; Savarino, E. V.; Zingone, F. | |
| Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak | 1-gen-2021 | Bertani, Lorenzo; Barberio, Brigida; Tricò, Domenico; Zanzi, Federico; Maniero, Daria; Ceccarelli, Linda; Marsilio, Ilaria; Coppini, Francesca; Lorenzon, Greta; Mumolo, Maria Gloria; Zingone, Fabiana; Costa, Francesco; Savarino, Edoardo Vincenzo | |
| Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) | 1-gen-2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M | |
| Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy | 1-gen-2021 | Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M | |
| Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) | 1-gen-2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M | |
| Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques | 1-gen-2021 | Bodini, Giorgia; Demarzo, Maria Giulia; Djahandideh, Afscin; Ziola, Sebastiano; Risso, Paolo; Bertani, Lorenzo; Baldissarro, Isabella; Testa, Tommaso; Marchi, Santino; Savarino, Edoardo; Giannini, Edoardo Giovanni | |
| Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study | 1-gen-2021 | Massimi, Davide; Barberio, Brigida; Bertani, Lorenzo; Costa, Francesco; Ferronato, Antonio; Facchin, Sonia; Cardin, Romilda; Cingolani, Linda; Casadei, Cesare; D’Incà, Renata; Zingone, Fabiana; Savarino, Edoardo Vincenzo | |
| Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers | 1-gen-2021 | Capecchi, R.; Migliorini, P.; Zanzi, F.; Maltinti, S.; Puxeddu, I.; de Bortoli, N.; Bellini, M.; Costa, F.; Marchi, S.; Bertani, L. | |
| Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator | 1-gen-2021 | Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V. | |
| Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis | 1-gen-2021 | Bertani, L.; Trico, D.; Zanzi, F.; Svizzero, G. B.; Coppini, F.; de Bortoli, N.; Bellini, M.; Antonioli, L.; Blandizzi, C.; Marchi, S. | |
| Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults | 1-gen-2021 | Visaggi, P.; Savarino, E.; Sciume, G.; Chio, T. D.; Bronzini, F.; Tolone, S.; Frazzoni, M.; Pugno, C.; Ghisa, M.; Bertani, L.; Bellini, M.; Savarino, V.; Peroni, D.; Marchi, S.; de Bortoli, N. | |
| Inflammatory bowel diseases: Is there a role for nutritional suggestions? | 1-gen-2021 | Bertani, L.; Ribaldone, D. G.; Bellini, M.; Mumolo, M. G.; Costa, F. | |
| Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients | 1-gen-2021 | Bertani, L.; Trico, D.; Pugliese, D.; Privitera, G.; Linsalata, G.; Zanzi, F.; Gloria Mumolo, M.; Barberio, B.; Monzani, F.; Marchi, S.; Guidi, L.; Blandizzi, C.; Armuzzi, A.; Costa, F. | |
| HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY | 1-gen-2021 | Bertani, L; Barberio, B; Trico, D; Zanzi, F; Maniero, D; Ceccarelli, L; Marsilio, I; Minciotti, M; Coppini, F; Lorenzon, G; Mumolo, Mg; Zingone, F; Costa, F; Savarino, Ev | |
| Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study | 1-gen-2021 | Cusato, J.; Bertani, L.; Antonucci, M.; Tomasello, C.; Caviglia, G. P.; Dibitetto, S.; Massano, A.; Mangia, M.; Mula, J.; Ceccarelli, L.; Costa, F.; Zanzi, F.; Astegiano, M.; Ribaldone, D. G.; D'Avolio, A. | |
| Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis | 1-gen-2022 | D'Antongiovanni, Vanessa; Pellegrini, Carolina; Benvenuti, Laura; Fornai, Matteo; Di Salvo, Clelia; Natale, Gianfranco; Ryskalin, Larisa; Bertani, Lorenzo; Lucarini, Elena; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Nemeth, Zoltan H; Haskó, György; Antonioli, Luca | |
| Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry | 1-gen-2022 | Tapete, Gherardo; Bertani, Lorenzo; Pieraccini, Alberto; Lynch, Erica Nicola; Giannotta, Martina; Morganti, Riccardo; Biviano, Ivano; Naldini, Sara; Mumolo, Maria Gloria; De Nigris, Francesca; Calella, Francesca; Bagnoli, Siro; Minciotti, Moira; Maltinti, Simona; Rentini, Silvia; Ceccarelli, Linda; Lionetti, Paolo; Milla, Monica; Costa, Francesco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile